Cargando…
Multimodality Imaging Guidance in Fulminant Myocarditis: When Endomyocardial Biopsy Is Not Amenable
Autores principales: | Kim, Jin Young, Kim, In-Cheol, Kim, Jae-Bum, Ko, Sung Min, Kim, Hyungseop |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Echocardiography
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7572255/ https://www.ncbi.nlm.nih.gov/pubmed/32462828 http://dx.doi.org/10.4250/jcvi.2019.0112 |
Ejemplares similares
-
Endomyocardial biopsy-proven fulminant lymphocytic myocarditis presenting with mid-apical ballooning
por: Miyamoto, Ryota, et al.
Publicado: (2023) -
Successful Heart Transplantation to a Fulminant Myocarditis Patient during COVID-19 Outbreak – Lessons Learned
por: Kim, In-Cheol, et al.
Publicado: (2020) -
Endomyocardial Biopsy for the Diagnosis of Transthyretin Cardiac Amyloidosis in the Era of Multimodality Imaging
por: Sunayama, Tsutomu, et al.
Publicado: (2021) -
Multimodal Findings of COVID-19-Related Rhabdomyolysis Complicated With Pericarditis Mimicking Fulminant Myocarditis
por: Arai, Riku, et al.
Publicado: (2021) -
Microthrombosis as a cause of fulminant myocarditis-like presentation with COVID-19 proven by endomyocardial biopsy
por: Nakatani, Satoshi, et al.
Publicado: (2022)